Purpose: To simultaneously image brain lesions and veins in multiple sclerosis. Methods: An interleaved sequence was developed to simultaneously acquire 3-dimensional T Ã 2 -weighted (or susceptibilityweighted (SW)) and fluid-attenuated inversion recovery (FLAIR) images on a 3T MRI system. The pulse sequence parameters were calculated to minimize signal perturbation from steady state while maintaining acceptable image contrast and scan time. Fifteen multiple sclerosis patients were enrolled in this prospective study and underwent a standard multiple sclerosis imaging protocol. In addition, SW and FLAIR images were acquired separately and also in an interleaved manner. The SW and FLAIR images were combined into one image to visualize lesions and penetrating veins. The contrast ratios between white matter lesions and penetrating veins were compared between the interleaved sequence and the individual noninterleaved acquisitions. Results: Interleaved scanning of the FLAIR and the SW pulse sequences was achieved, producing aligned images, and with similar image contrast as in the noninterleaved images. A total of 1076 lesions were identified in all patients on the combined SW-FLAIR image, of which 968 lesions (90%) had visible penetrating veins. Lesion-to-vein contrast ratio was 32.7 6 17.9 (mean 6 standard deviation) for the interleaved sequence compared with 28.1 6 13.7 using the separate acquisitions (P < 0.001). Conclusion: The feasibility of interleaved acquisition of SW and FLAIR images was demonstrated. This sequence provides selfregistered images and facilitates the visualization of veins in brain lesions.
INTRODUCTION
Detection of focal lesions in the white matter (WM) plays a central role in the radiologic diagnosis of multiple sclerosis (MS) (1) . White matter lesions are not specific to MS, however, as they are also found in other neurological conditions such as small vessel disease, migraine, acute disseminated encephalomyelitis, and neuromyelitis optica (2, 3) . Visualization of veins running through the lesions is thought to be an additional confirmatory feature for the diagnosis of MS (4) (5) (6) . Veins are more commonly visualized on susceptibility-weighted (SW, or T Ã 2 -weighted) gradient-echo sequences (7) (8) (9) . Combining the information from images such as T 2 -weighted fluidattenuated inversion recovery (FLAIR), which visualizes lesions with high contrast, and SW images, which depict the veins more clearly, may greatly facilitate the identification of perivenous lesions (10, 11) . The combined images show the MS lesions as hyperintense signal penetrated by the hypointense veins, likely improving detection of lesions with penetrating veins.
The individual FLAIR and T Ã 2 /SW images may be combined in various ways, such as by directly multiplying the FLAIR and the magnitude T Ã 2 images as in the FLAIR* technique (11) , or by multiplying the FLAIR image by a calculated SW imaging (SWI) phase image (8) , as in FLAIR SWI (10) . Synthetic images constructed by combining separate acquisitions are prone to patient movement between the two scans. This necessitates the use of image-registration techniques to align the images, which might cause image blurring and are error-prone. As a result, the reconstruction pipeline becomes complicated, less robust, and slower. To minimize imageregistration errors and improve practical implementation, we propose an interleaved pulse sequence to simultaneously acquire SW and FLAIR images. In this report, we describe the interleaved pulse sequence and demonstrate its feasibility for visualizing veins penetrating lesions in MS.
METHODS

Noninterleaved SW and FLAIR Protocols
Full-brain 3-dimensional (3D) FLAIR images were acquired using sagittal 3D acquisition as part of the site's standard MS protocol. In addition, 3D SW (T the same field of view and voxel size ¼ 0.7 Â 0.7 Â 0.5 mm, TR/echo time ¼ 47/25 ms, flip angle ¼ 20 , number of signal averages ¼ 1, EPI factor ¼ 15, and sensitivity-encoding factor ¼ 2 Â 2, and scan duration of 2 min 22 s.
Interleaved SW-FLAIR
The proposed interleaved 3D SW-FLAIR pulse sequence consists of alternating FLAIR and gradient-echo (GRE) modules separated by two preparation periods (Fig. 1) . The FLAIR module consists of an inversion pulse, inversion delay period, and a variable flip-angle turbo spin-echo readout. The SW module consists of a train of EPI-accelerated gradient-echo (EPI-GRE) readout segments. Two preparation intervals are inserted before the start of the FLAIR and EPI-GRE modules, respectively, to mitigate the interruption in the steady state. The first preparation delay period (TD1) before the FLAIR readout is chosen to allow magnetization recovery through T 1 relaxation that produces image contrast similar to the noninterleaved FLAIR image. In the second preparation period (TD2), before the start of the EPI-GRE module, a preparation sequence is performed consisting of a train of radiofrequency pulses of the same flip angle and TR as in the EPI-GRE sequence, to drive the magnetization to approach its steady-state value and reduce k-space modulation.
Bloch equation simulation of the interleaved sequences were performed using the extended phase graph method (12) , assuming the following (M 0 , T 1 , T 2 ) parameters: WM (0.7, 850 ms, 85 ms); gray matter (GM) (0.8, 1400 ms, 100 ms); cerebrospinal fluid (CSF) (1.0, 4000 ms, 2000 ms); and blood (1.0, 1500 ms, 30 ms). Simulations were repeated to account for spatial variations in the B 1 field. The TR of the FLAIR module in the interleaved sequence was reduced to 2500 ms, approximately equal to the shortest possible TR. The TD1 delay interval was determined based on simulations of the tissue signal at various TD1 delays, to assure sufficient CSF suppression and signal-to-noise ratio of WM and GM. Next, the number of radiofrequency pulses in the GRE-preparation module (TD2 interval) was chosen such that the magnetization of GM, WM, and veins reach 90% of their steadystate values, accounting for up to 10% variation in the flip angle. Following the TD2 preparation module, an EPI-GRE readout train consisting of 45 repetition periods was collected. This pulse train was chosen such that FLAIR and GRE take the same number of shots (N shot ¼ 69) to complete the scan. Both pulse sequences used a linear k-space ordering such that both sequences crossed the center of k-space at approximately the same time.
Multiple Sclerosis Studies
Multiple Sclerosis Subjects
Magnetic resonance imaging studies of the brain were performed using a 15-channel head coil on a 3T Ingenia scanner (Philips Healthcare, Best, Netherlands). Fifteen MS patients were enrolled in this study (nine women and six men, age ¼ 43 6 11 (mean 6 standard deviation) years). Table 1 summarizes the patients' clinical characteristics. The study was approved by our institutional review board, and all volunteers gave written, informed consent.
Imaging Protocol
A standard MS imaging protocol was extended to include the acquisition of 3D SW images. The individual 3D FLAIR and 3D SW images were acquired with minimal delay between the two acquisitions to minimize position differences. The interleaved 3D SW and FLAIR sequence was acquired immediately after the noninterleaved sequences, using identical spatial coverage and resolution as in the separate 3D FLAIR and SW protocols. The implementation used a framework for interleaved scanning based on rapid switching between separately defined scans at arbitrary time points (13) . The scan parameters of all pulse sequences were the same as described in the previous section, with the values for TD1 and TD2 preparation as reported in the "Results" section.
Data Analysis
All images were interpolated to a 0.5 Â 0.5 Â 0.5 mm resolution and reformatted into the axial plane. The FLAIR* and the interleaved FLAIR* images were reconstructed An experienced neuroradiologist inspected the FLAIR* images and identified the locations of all WM lesions, separately marking lesions with visible penetrating veins. Regions of interest (ROIs) were placed in the identified WM lesions such that the ROI samples the lesion and the penetrating vein, if visible. Location-matched ROIs were placed on the interleaved FLAIR* images. For each ROI with visible veins, the maximum and the minimum intensity values were attributed to the lesion and the vein, respectively. To mitigate the effect of noise, the top and the bottom 5% (chosen somewhat arbitrarily) of the intensity values within the ROI (size $100 pixels) were averaged to yield S lesion and S vein . The contrast ratio between lesions and veins (CR lesion-vein ) was calculated using the following formula: CR ¼ (S lesion -S vein )/(S lesion þS vein ). The Wilcoxon signed-rank test was used to test for differences in the contrast ratios on the FLAIR* and the interleaved FLAIR* images using the MATLAB Statistics Toolbox (MathWorks, Natick, MA, USA). Statistical significance was assumed for P < 0.05. All of the values were expressed as (mean 6 standard) deviation.
RESULTS
Simulations
Variations in the preparation period TD1 affected CSF suppression, but had little effect on the WM and GM levels (Fig. 2) . Therefore, the TD1 delay was selected to provide comparable T 1 recovery and CSF suppression, and to match the scan time of the noninterleaved FLAIR sequence. TD1 was set to 2310 ms, for an effective FLAIR TR of 4810 ms. The small 10-ms difference in TR from the original FLAIR was the result of numerical round-off needed for scan interleaving. The number of RF pulses in the GRE-preparation module (TD2 interval) required to reach 90% of the steady-state value of the magnetization of WM, GM, and veins was 19 to 27, accounting for 10% error in flip angle. Thus, a train of 25 pulses was used for a total preparation time TD2 of 1175 ms, which allowed recovery of WM, GM, and veins to 97, 93, and 92% of their steady-state values, respectively, at the nominal flip angle (Fig. 2) . The total scan duration to acquire the interleaved 3D-SW and FLAIR images was 9 min 13 s.
Multiple Sclerosis Studies
Scanning with the interleaved sequence was completed successfully on all patients. Figure 3 shows representative FLAIR, SW (T Ã 2 -weighted), and calculated FLAIR* images acquired with the conventional and the proposed interleaved sequences from one MS patient. Visually, tissue contrast and image quality of the interleaved FLAIR and T Ã 2 -weighted images were comparable to those from the separate acquisitions. A slight signal modulation was observed in the interleaved T Ã 2 -weighted images (Fig. 3d) . The computed FLAIR* images show the veins running through MS lesions (arrows) with similar conspicuity in both scans. Figure 4 shows corresponding slices from FLAIR* and interleaved FLAIR* images from two MS patients, again showing the visibility of lesion-penetrating veins on both sequences.
Although the separate FLAIR and T Ã 2 acquisitions were performed with minimal delay between the two scans to minimize motion, motion was noted in a few cases. Image registration was necessary to correct for position errors. In contrast, the interleaved sequence consistently produced aligned images (Fig. 4) . A total of 1076 lesions were identified in all patients. The average number of lesions per subject was 72 6 59. Of all lesions, 968 lesions (90%) had visible veins. The average WM lesion-to-vein CR was 32.7 6 17.9 with the interleaved sequence, compared with 28.1 6 13.7 with the separate acquisitions of FLAIR and SW (P < 0.001).
DISCUSSION
The potential diagnostic specificity of the central vein sign has recently attracted increased interest in the MS research community (14, 15) . The introduction of methods combining SW and FLAIR images allowed visualization and assessment of the veins inside the MS plaques (16) . We have demonstrated the feasibility of an interleaved sequence for simultaneous acquisition of SW and FLAIR images, which produces self-registered images. This approach simplifies the reconstruction pipeline, avoids errors and image blur arising from image registration, and allows almost real-time availability of the combined SW-FLAIR image.
In this study, 90% of the lesions showed penetrating veins, in agreement with the previous work showing 69 to 89% prevalence of vein in MS lesions (16) (17) (18) . A small increase in lesion-vein contrast was observed in the interleaved FLAIR* image, which is likely caused by slight differences in the relaxation pathways in the interleaved sequence. The primary goal of this study was to show feasibility of interleaved SW and FLAIR acquisition while preserving image contrast. Hence, the observed contrast improvement was rather incidental. However, we recognize that the interleaved sequence carries the potential to use the interaction between the FLAIR and the GRE modules to optimize a specific image quality target such as lesion-vein contrast in the SW-FLAIR image, lesion contrast on FLAIR, or CSF suppression on GRE. These targets will be the subject of a future study.
Head motion may occur any time during the scan. In practice, however, patients are usually instructed to remain still during data acquisition, and are allowed to adjust their position for more comfort in between individual acquisitions. Motion, therefore, more frequently occurs between the scans. Because the position of the head is determined primarily by the time of acquiring the center of k-space, interleaved acquisition, which acquires the center of k-space of the two images within a few seconds, produces images with the same head position. In contrast, the temporal separation is a few minutes when the two images are acquired separately, increasing the odds of interscan patient movement. In contrast, intrascan patient motion alters the point spread function and causes image blurring or ghosting, but does not affect position. All pulse sequences, separate or interleaved, are susceptible to blurring/ghosting from intrascan motion, but the prolonged apparent acquisition times of the interleaved sequences make it slightly more susceptible to intrascan motion.
The method by which the SW and FLAIR images are combined may also provide another way to improve visualization of penetrating veins in a fashion similar to the optimized combination of T 2 -weighted and FLAIR images for enhancing lesion contrast (19) . Optimized versions of FLAIR-SWI and FLAIR* (10,11) may similarly be obtained using a combination of T Ã 2 or SWI images with FLAIR that maximizes a measure of veins and iron detectability and lesion-vein contrast.
We implemented the interleaved SW-FLAIR sequence using recovery periods and preparation modules to control the magnetization evolution to minimize disturbance of the steady-state conditions for the individual pulse sequences. Because of its long relaxation times, CSF did not reach steady state during the short TD2 period. Residual signal modulation from CSF was observed on the interleaved SW images, although it did not adversely affect the final lesion-vein contrast. A preparation module to further attenuate the CSF signal inconsistency on the T Ã 2 acquisition, such as using an inversion pulse, may help to alleviate this problem.
The interleaved sequence permitted simultaneous SW and FLAIR acquisition at the expense of an approximate 80-s increase in scan time. Although long scan times increase the susceptibility to intrascan motion effects, we did not observe large motion effects in this study. Techniques using compressed sensing can help to reduce the data acquisition time (20) . In addition, redundant information in the two sequences may also allow a multimodal compressed-sensing implementation (21, 22) that could further reduce the scan time. Ongoing studies will explore these methods.
In conclusion, we have developed and implemented an interleaved sequence for simultaneous acquisition of SW and FLAIR images. The proposed pulse sequence eliminates the need for image registration and avoids the associated registration errors and blur. This will help future development of methods that optimally combine these images for improved visualization of lesion-penetrating veins.
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